Literature DB >> 1891957

World-wide epidemiology of Haemophilus influenzae meningitis; industrialized versus non-industrialized countries.

H A Bijlmer1.   

Abstract

The epidemiology of Haemophilus influenzae meningitis in non-industrialized areas shows considerable differences from that in the industrialized world. The incidence rates among Alaskan Eskimos, Navaho and White Mountain Indians, Australian Aboriginals and among populations in Africa such as Gambians and Senegalese are three- to fourfold higher than those in the USA and up to ten times higher than those in Europe. The peak age in populations with a high incidence is around 5 to 6 months of age compared to 9 months of age in other countries. The case fatality rate (CFR) is not related to the state of industrialization but seems to be more dependent on the accessibility of health care facilities. Africa the CFR is about ten times higher than that seen elsewhere. Apart from other dissimilarities such as the pattern of serotypes causing disease and the transmission rate, the epidemiology of Hib disease is sufficiently different from industrialized areas that it demands a thorough testing of a conjugated Hib vaccine before it can be introduced on a large scale in populations in non-industralized areas.

Entities:  

Keywords:  Bacterial And Fungal Diseases; Biology; Communicable Diseases; Diseases; Epidemics; Incidence; Infections; Literature Review; Measurement; Neurologic Effects; Physiology; Research Methodology; World

Mesh:

Year:  1991        PMID: 1891957     DOI: 10.1016/0264-410x(91)90172-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Pharmacoeconomics of immunisation: a review.

Authors:  R van den Oever; D de Graeve; B Hepp; A Stroobant; D Walckiers; V Van Casteren; F Van Loock; G Ducoffre; J Dewatripont; P Jacques
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

2.  Haemophilus influenzae: then and now.

Authors:  J Z Jordens; M P Slack
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

3.  The epidemiology of Haemophilus influenzae type b disease in the Republic of Ireland.

Authors:  J Fogarty; A C Moloney; J B Newell
Journal:  Epidemiol Infect       Date:  1995-06       Impact factor: 2.451

4.  Biotypes and serotypes of Haemophilus influenzae from patients with meningitis in the city of São Paulo, Brazil.

Authors:  I M Landgraf; M F Vieira
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

5.  Immunogenicity of routine vaccination against diphtheria, tetanus, and Haemophilus influenzae type b in Asian infants born in the United Kingdom.

Authors:  R Booy; E A Haworth; K A Ali; H M Chapel; E R Moxon
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

Review 6.  Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates.

Authors:  H Peltola
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

7.  Efficacy of Haemophilus influenzae type b vaccination of children: a meta-analysis.

Authors:  C O Obonyo; J Lau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-02       Impact factor: 3.267

Review 8.  Classification, identification, and clinical significance of Haemophilus and Aggregatibacter species with host specificity for humans.

Authors:  Niels Nørskov-Lauritsen
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 9.  Long Term Impact of Conjugate Vaccines on Haemophilus influenzae Meningitis: Narrative Review.

Authors:  Mary Paulina Elizabeth Slack
Journal:  Microorganisms       Date:  2021-04-21

10.  Etiology and antimicrobial resistance patterns of acute bacterial meningitis in children: a 10-year referral hospital-based study in northwest iran.

Authors:  Babak Abdinia; Mohammad Ahangarzadeh Rezaee; Shahram Abdoli Oskouie
Journal:  Iran Red Crescent Med J       Date:  2014-07-05       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.